SANTOS LTD/ AU000000STO6 /
2024-05-10 8:10:54 AM | Chg. +0.0910 | Volume | Bid9:58:44 PM | Ask9:58:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.6730EUR | +1.99% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 15.61 bill.EUR | - | - |
GlobeNewswire
05-07
Hitachi Energy supports long-term operation of largest HVDC-connected wind energy project in U.S.
GlobeNewswire
05-07
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Upd...
GlobeNewswire
04-24
Acrivon Therapeutics Reports Initial Positive Clinical Data for ACR-368 and Pipeline Program Progres...
GlobeNewswire
04-24
Dickey’s Barbecue in the Lineup for Dallas Cowboys Draft Party presented by Miller Lite
GlobeNewswire
04-24
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 20...
GlobeNewswire
04-23
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology...
GlobeNewswire
04-23
Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
Newsfile Corp
04-18
Creative Heart Awakenings' Founder Announces the Launch Event of Her Book "HeART Healing for Radiant...
GlobeNewswire
04-17
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including O...
GlobeNewswire
04-10
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon P...
GlobeNewswire
04-08
Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist De...
GlobeNewswire
04-08
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib